Jim Koziarz, Ph.D.
Chief Executive Officer
Jim has been CEO of Rubicon Genomics since December, 2008; prior to that he was Chairman of the Board. Jim has a Ph.D. in Biochemistry from the University of Chicago and worked at Abbott Laboratories for 25 years where he held the position of Corporate Vice President of Research and Development for his last 11 years. Jim also served as Business Unit General Manager for two separate units in Abbott Diagnostics. After retiring from Abbott in 2004, Jim has been active in working with start-up companies and currently holds two board positions for other biotech companies.
Jim lives in Highland Park, Illinois, with his wife and son and daughter. He is an ardent sports enthusiast who cheers on his Chicago White Sox and Blackhawks.
John Langmore, Ph.D.
Co-Founder and Chief Scientific Officer
John co-founded Rubicon Genomics in 2000. He spent 23 years as a professor in the Department of Biology and 6 years as chair of the Biophysics Research Division at the University of Michigan. He did his Ph.D. studies at the University of Chicago and postdoctoral studies at the MRC-LMB in Cambridge and Biozentrum in Basel. John has numerous patents and over 40 peer-reviewed publications on DNA, nucleosome, telomere, and chromosome structure.
In his spare time, John enjoys the solitude of his country home where he harvests solar energy from the forest, orchard, garden and roof to sustain his family.
Betsy Long, MSA
Chief Financial Officer
Betsy joined Rubicon Genomics in May of 2009. She serves as CFO of the ARCH Development investment team where she plays a key role in guiding multiple companies through development. Betsy earned her CPA and MSA in Accountancy from Western Michigan University.
When not working, Betsy enjoys spending time with her grandchildren and playing golf.
Christine Haakenson, Ph.D.
President and Chief Operating Officer
Christine joined Rubicon Genomics in 2012 with over 12 years of experience in research program management and business process optimization. She received her Ph.D. in Biochemistry and Molecular Biology from Georgetown University and holds a B.S. in Chemical Engineering from Cornell University.
Christine enjoys travelling to visit family and friends and spending quiet hours hiking and skiing.
Emmanuel Kamberov, Ph.D.
Vice President Research
Emmanuel has been an employee of Rubicon Genomics since 2000 and now serves as Vice President of Research, spearheading the development of new products. He holds a Ph.D. in Biochemistry from the Bulgarian Academy of Science and was an Assistant Professor of Biochemistry at the University of Plovdiv. He moved to the United States in 1992 and held various academic positions at Wayne State University and the University of Michigan before joining RGI as a Senior Scientist. Emmanuel is a well published author and is inventor or co-inventor on more than 20 US and WO patents and applications.
In his spare time, Emmanuel transforms the electronic music world as Dj Emmo and enjoys spending time with his wife and two sons.
Karl Hecker, Ph.D.
Vice President Product Development
Karl joined Rubicon Genomics in October of 2014 bringing over 25 years of scientific experience in chemistry and molecular biology and more than 15 years of product development experience. He held positions of increasing importance in several companies including HTG Diagnostics, Quidel Corporation, PerkinElmer and Invitrogen. He earned a Ph.D. from Florida State University and completed postdoctoral research at Florida State University and Harvard Medical School.
When not working, Karl enjoys spending time with family and friends and sharing the products of his amateur cooking and baking skills.
Jamie Wibbenmeyer, Ph.D.
Vice President Business Development
Jamie joined Rubicon Genomics mid-2013 to head the business development and marketing efforts. She has over 12 years of experience in the Life Science tools industry, having worked at several start-ups as well as Bio-Rad Laboratories. She earned her Ph.D. in Biochemistry from the University of Houston and has several peer-reviewed publications.
Jamie is a wine enthusiast and grows grapes on acreage in the foothills of California.
Takao Kurihara, Ph.D.
Senior Director Commercial Operations
Takao joined Rubicon Genomics in 2002. He has directed the manufacturing of PicoPLEX and ThruPLEX products since 2009. He received his Ph.D. in Molecular Biology from Princeton University, received post-doctoral training at Bristol-Myers Squibb, and has 16 years of biotechnology experience including R&D, operations, and management. He is co-inventor on several Rubicon Genomics patents, coordinated OEM manufacturing of GenomePlex® and TransPlex® kits in 2003-2004, and managed Commercial Service activities from 2004-2009.
Takao enjoys homebrewing as a natural extension of his graduate school lab work with yeast.
Matthew Carroll, MS
Senior Director of Internal Operations and Bioinformatics
Matthew joined Rubicon Genomics to lead the Program Management team in 2013 and was promoted to Director of Internal Operations and Bioinformatics in 2014. Matthew joined Rubicon Genomics from NextGen Sciences in Ann Arbor, MI where he led contract research efforts for clients across the pharmaceutical, biotechnology and diagnostics landscape to develop quantitative assays for the discovery and qualification of protein biomarkers using multiple reaction monitoring (MRM) mass spectrometry. Prior to NextGen, Matthew was a Senior Scientist at Pfizer Inc., where he was involved in early stage research projects in the inflammation and dermatology therapeutic areas.
Matthew received his M.S. from the University of Michigan in Molecular, Cellular, and Developmental Biology.
In his spare time, Matthew coaches basketball and soccer and enjoys spending time with his wife and two daughters.